0001140361-18-008303.txt : 20180214
0001140361-18-008303.hdr.sgml : 20180214
20180214170813
ACCESSION NUMBER: 0001140361-18-008303
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20180214
DATE AS OF CHANGE: 20180214
EFFECTIVENESS DATE: 20180214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarissa Capital Management LP
CENTRAL INDEX KEY: 0001577524
IRS NUMBER: 900924432
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15935
FILM NUMBER: 18613477
BUSINESS ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 203-302-2330
MAIL ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001577524
XXXXXXXX
12-31-2017
12-31-2017
Sarissa Capital Management LP
660 STEAMBOAT ROAD
GREENWICH
CT
06830
13F HOLDINGS REPORT
028-15935
N
Alexander J. Denner, Ph.D.
Chief Investment Officer
203-302-2330
/s/ Alexander J. Denner
Greenwich
CT
02-14-2018
0
11
390650
false
INFORMATION TABLE
2
form13fInfoTable.xml
ABBVIE INC.
COM
00287Y109
967
10000
SH
SOLE
10000
0
0
ACHILLION PHARMACEUTICALS INC
COM
00448Q201
7200
2500000
SH
SOLE
2500000
0
0
ALLERGAN PLC
SHS
G0177J108
42089
257300
SH
SOLE
257300
0
0
APRICUS BIOSCIENCES INC
COM NEW
03832V307
2664
1447906
SH
SOLE
1447906
0
0
BIOGEN INC
COM
09062X103
131842
413858
SH
SOLE
413858
0
0
BIOVERATIV INC
COM
09075r100
62816
1165000
SH
SOLE
1165000
0
0
INNOVIVA INC
COM
45781M101
51945
3600705
SH
SOLE
3600705
0
0
INTERCEPT PHARMACEUTICALS INC
COM
45845P108
10649
182300
SH
SOLE
182300
0
0
IRONWOOD PHARMACEUTICALS INC.
COM CLA
46333X108
24733
1650000
SH
SOLE
1650000
0
0
MEDICINES CO
COM
584688105
52547
1922000
SH
SOLE
1922000
0
0
NOVELION THERAPEUTICS INC
COM NEW
67001K202
3198
1025000
SH
SOLE
1025000
0
0